Q3 2024 Earnings Forecast for IM Cannabis Corp. Issued By Roth Capital (NASDAQ:IMCC)

IM Cannabis Corp. (NASDAQ:IMCC) – Analysts at Roth Capital lowered their Q3 2024 earnings per share estimates for IM Cannabis in a note issued to investors on Thursday, August 15th. Roth Capital analyst S. Fortune now forecasts that the company will post earnings per share of ($1.36) for the quarter, down from their previous forecast of ($0.90). The consensus estimate for IM Cannabis’ current full-year earnings is ($4.32) per share. Roth Capital also issued estimates for IM Cannabis’ Q4 2024 earnings at ($1.15) EPS, FY2024 earnings at ($5.61) EPS, Q1 2025 earnings at ($0.93) EPS, Q2 2025 earnings at ($0.68) EPS, Q3 2025 earnings at ($0.41) EPS, Q4 2025 earnings at ($0.31) EPS and FY2025 earnings at ($2.33) EPS.

IM Cannabis Price Performance

Shares of NASDAQ IMCC opened at $3.02 on Monday. The company has a debt-to-equity ratio of 0.05, a current ratio of 0.65 and a quick ratio of 0.40. The stock has a fifty day moving average price of $2.71 and a 200 day moving average price of $2.99. IM Cannabis has a 1-year low of $1.13 and a 1-year high of $8.10. The company has a market cap of $6.74 million, a PE ratio of -0.63 and a beta of 0.47.

Institutional Trading of IM Cannabis

A hedge fund recently raised its stake in IM Cannabis stock. AdvisorShares Investments LLC grew its holdings in shares of IM Cannabis Corp. (NASDAQ:IMCC) by 39.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 620,762 shares of the company’s stock after purchasing an additional 174,086 shares during the period. AdvisorShares Investments LLC owned approximately 27.80% of IM Cannabis worth $278,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 7.68% of the company’s stock.

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.